Head-to-head · Cost-Efficiency Index
Rewinding RX vs Walgreens Weight Management
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rewinding RX
Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.
Visit Rewinding RXWalgreens Weight Management
Cost-first shoppers who want brand-name FDA-approved Wegovy access at a discounted self-pay starter rate from a national pharmacy chain they already trust.
Visit Walgreens Weight ManagementThe verdict
Rewinding RX and Walgreens Weight Management tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Rewinding RX (ranked #150, a hair above #155) — Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line. But Walgreens Weight Management is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rewinding RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rewinding RX | Walgreens Weight Management |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $139/mo (microdose tier, compounded) | $199/mo (0.25 mg dose, brand-name) |
| Tirzepatide / mo | $189/mo (microdose tier, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,668 | $2,388 |
| Tirzepatide / yr (modeled) | $2,268 | — |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #150 | #155 |
Rewinding RX
66/100Where the value is
- Flat pricing within each product regardless of dose
- Publishes the FDA compounded-medication disclaimer and states pharmacies are '503A'/'503B' FDA-regulated facilities
- Corporate entity is disclosed (Rewinding RX Ltd.)
The tradeoffs
- Four separate GLP-1 SKUs exist at four different prices under similar names
- No compounding pharmacy is individually named, only generic '503A'/'503B' language
Walgreens Weight Management
66/100Where the value is
- Backed by a major, publicly-traded national pharmacy chain (Walgreens) rather than an unknown startup
- Dispenses FDA-approved Wegovy, not compounded medication
- No monthly platform subscription fee — pay-per-visit ($49) instead
The tradeoffs
- The '$49 per visit, no subscription' headline is easy to misread as the total monthly cost — it is only the clinician fee; the drug itself costs $149-199+/mo on top
- Published prices are starter-dose only; Walgreens does not disclose what the maintenance dose costs once a patient titrates up, so real steady-state cost is likely higher
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.